4//SEC Filing
ZUCCONI THEODORE DANIEL 4
Accession 0001179022-18-000026
CIK 0001133416other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 4:31 PM ET
Size
8.4 KB
Accession
0001179022-18-000026
Insider Transaction Report
Form 4
ZUCCONI THEODORE DANIEL
DirectorCEO and President
Transactions
- Exercise/Conversion
Stock option (right to buy)
2018-04-16−4,000→ 27,250 totalExercise: $0.89Exp: 2026-12-15→ Common stock (4,000 underlying) - Exercise/Conversion
Common Stock
2018-04-16$0.89/sh+4,000$3,560→ 5,083 total - Sale
Common Stock
2018-04-16$3.58/sh−4,000$14,320→ 1,083 total
Footnotes (1)
- [F1]The options vested 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001413699
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 4:31 PM ET
- Size
- 8.4 KB